Key covid-19 updates, government guidance and insight for pharma and health.
LATEST >
NICE guidance does not recommend AstraZeneca’s Evusheld
The National Institute for Health and Care Excellence (NICE) has issued draft guidance for public consultation which does not recommend Evusheld (tixagevimab-cilgavimab) for preventing...
- Advertisement -
Sanofi and GSK submit data for their COVID-19 vaccine
Sanofi and GlaxoSmithKline (GSK) have announced that they intend to submit data from both...
Success for world’s largest study into new antiviral treatments against COVID-19
Over ten thousand participants from across the UK have now taken part in the...
JCVI updates COVID-19 vaccination guidance for 5 to 11 year olds
The Joint Committee on Vaccination and Immunisation (JCVI) is now advising a non-urgent offer...
- Advertisement - 
- Advertisement -
Pfizer and BioNTech initiate clinical study of Omicron vaccine
Pfizer and BioNTech have announced the initiation of a clinical study to evaluate the safety,...
MHRA approves Pfizer’s COVID-19 antiviral treatment Paxlovid
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved COVID-19 antiviral treatment, Paxlovid...
UK marks 132 million COVID-19 vaccinations in 2021
Around 132 million COVID-19 vaccinations were administered across all four nations of the UK in 2021, as part of the largest vaccination programme in...
COVID: A new wave of interest in pharma, what learnings can we take into the future?
"We have a responsibility to build on this extraordinary period of self-education and find ways of talking about what we do – beyond vaccines"
